0001471363-25-000001.txt : 20250623 0001471363-25-000001.hdr.sgml : 20250623 20250623104151 ACCESSION NUMBER: 0001471363-25-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250623 DATE AS OF CHANGE: 20250623 EFFECTIVENESS DATE: 20250623 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BACCH Laboratories, Inc. CENTRAL INDEX KEY: 0001471363 ORGANIZATION NAME: EIN: 800309424 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-354019 FILM NUMBER: 251063402 BUSINESS ADDRESS: STREET 1: 747 SW 2ND AVENUE, IMB#11 CITY: GAINESVILE STATE: FL ZIP: 32601 BUSINESS PHONE: 352-870-3799 MAIL ADDRESS: STREET 1: 747 SW 2ND AVENUE, IMB#11 CITY: GAINESVILE STATE: FL ZIP: 32601 FORMER COMPANY: FORMER CONFORMED NAME: Bit Cauldron Corp DATE OF NAME CHANGE: 20090831 D/A 1 primary_doc.xml X0708 D/A LIVE 0001471363 BACCH Laboratories, Inc. 747 SW 2ND AVENUE, IMB#11 GAINESVILE FL FLORIDA 32601 352-870-3799 DELAWARE Bit Cauldron Corp Corporation true James Mentz c/o BACCH Laboratories, Inc. 747 SW 2nd Avenue, IMB#11 Gainesville FL FLORIDA 32601 Executive Officer Director Richard Allen c/o BACCH Laboratories, Inc. 747 SW 2nd Avenue, IMB#11 Gainesville FL FLORIDA 32601 Director Robert Mentz c/o BACCH Laboratories, Inc. 747 SW 2nd Avenue, IMB#11 Gainesville FL FLORIDA 32601 Executive Officer Benjamin Andrew Hoover c/o BACCH Laboratories, Inc. 747 SW 2nd Avenue, IMB#11 Gainesville FL FLORIDA 32601 Director Garrett Gleim c/o BACCH Laboratories, Inc. 747 SW 2nd Avenue, IMB#11 Gainesville FL FLORIDA 32601 Director Edgar Choueiri c/o BACCH Laboratories, Inc. 747 SW 2nd Avenue, IMB#11 Gainesville FL FLORIDA 32601 Director Other Technology Decline to Disclose 06b true 0001471363-19-000002 2019-11-08 true true Simple Agreement for Future Equity false 0 n/a None Four Points Capital Partners LLC 43149 55A E. Ridgewood Avenue Suite 12 Ridgewood NJ NEW JERSEY 07450 All States false 9000000 2916000 6084000 false 48 20250 0 0 Other than the payment of salaries and other compensation and benefits, no officer, director, manager or promoter will receive any payments from the proceeds of this offering. false BACCH Laboratories, Inc. /s/ Robert Mentz Robert Mentz Chief Financial Officer 2025-06-17